Publication

Complementary and Alternative Medicine Use in African Americans With Rheumatoid Arthritis

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Ashutosh Tamhane, University of Alabama BirminghamGerald McGwin, University of Alabama BirminghamDavid T. Redden, University of Alabama BirminghamLaura B. Hughes, University of Alabama BirminghamElizabeth E. Brown, University of Alabama BirminghamAndrew O. Westfall, University of Alabama BirminghamDoyt L Conn, Emory UniversityBeth L. Jonas, University of North CarolinaEdwin Smith, Emory UniversityRichard D. Brasington, Washington UniversityLarry W. Moreland, University of PittsburghS. Louis Bridges, Jr., University of Alabama BirminghamLeigh F. Callahan, University of North Carolina
Language
  • English
Date
  • 2014-02-01
Publisher
  • Wiley: 12 months
Publication Version
Copyright Statement
  • Copyright © 2014 by the American College of Rheumatology.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 2151-464X
Volume
  • 66
Issue
  • 2
Start Page
  • 180
End Page
  • 189
Grant/Funding Information
  • Supported by the NIH (contract N01-AR-02247, grant P60-AR-48095 to the University of Alabama at Birmingham Multidisciplinary Clinical Research Center; and grant UL1-TR-000165 from the National Center for Advancing Translational Sciences; and National Center for Research Resources).
Abstract
  • Objective: Racial/ethnic differences with regard to complementary and alternative medicine (CAM) use have been reported in the US. However, specific details of CAM use by African Americans with rheumatoid arthritis (RA) are lacking. Methods: Data were collected from African Americans with RA enrolled in a multicenter registry regarding the use of CAM, including food supplements, topical applications, activities, and alternative care providers. Factors associated with CAM use by sex and disease duration were assessed using t-test, Wilcoxon's rank sum test, chi-square test, and logistic regression analyses. Results: Of the 855 participants, 85% were women and mean age at enrollment was 54 years. Overall, ever using any of the CAM treatments, activities, and providers was 95%, 98%, and 51%, respectively (median of 3 for number of treatments, median of 5 for activities, and median of 1 for providers). Those with longer disease duration (>2 years) were significantly more likely (odds ratio ≥2.0, P < 0.05) to use raisins soaked in vodka/gin, to take fish oils, or to drink alcoholic beverages for RA treatment than those with early disease. As compared to men, women were significantly (P < 0.05) more likely to pray/attend church, write in a journal, and use biofeedback, but were less likely to smoke tobacco or topically apply household oils for treatment of RA. Conclusion: CAM use was highly prevalent in this cohort, even in individuals with early disease. Health care providers need to be aware of CAM use as some treatments may potentially have interactions with conventional medicines. This could be important within this cohort of African Americans, where racial disparities are known to affect access to conventional care.
Author Notes
  • Ashutosh Tamhane, MD, PhD, MSPH, University of Alabama at Birmingham, 1665 University Boulevard, RPHB 514-A, Birmingham, AL 35294. tamhane@uab.edu
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items